Co-Authors
This is a "connection" page, showing publications co-authored by Beth Russell and Charlotte Moss.
Connection Strength
1.930
-
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London. Br J Cancer. 2021 09; 125(7):939-947.
Score: 0.241
-
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients. Cancers (Basel). 2021 May 19; 13(10).
Score: 0.237
-
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London. Front Oncol. 2020; 10:1279.
Score: 0.223
-
One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer. Cancer Control. 2020 Jul-Aug; 27(3):1073274820950844.
Score: 0.223
-
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? Ecancermedicalscience. 2020; 14:ed98.
Score: 0.219
-
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020; 14:1023.
Score: 0.219
-
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020; 14:1022.
Score: 0.218
-
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience. Cancers (Basel). 2021 Jul 16; 13(14).
Score: 0.060
-
Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19. Tumori. 2021 Apr 12; 3008916211007927.
Score: 0.059
-
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study. Eur J Cancer. 2021 06; 150:190-202.
Score: 0.059
-
Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan. Cancers (Basel). 2021 03 30; 13(7).
Score: 0.059
-
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer. 2021 03; 9(3).
Score: 0.058
-
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. Cancer Cell. 2021 02 08; 39(2):257-275.e6.
Score: 0.058